TY - JOUR
T1 - Chemotherapy-induced nausea and vomiting
T2 - Contemporary approaches to optimal management
AU - Grunberg, Steven
AU - Clark-Snow, Rebecca A.
AU - Koeller, Jim
PY - 2010/3/1
Y1 - 2010/3/1
N2 - Introduction: Chemotherapy-induced nausea and vomiting remains a significant problem for cancer patients. Discussion: Patient factors such as polypharmacy, medication costs, mucositis, and depression may hinder good antiemetic control, while high workloads, poor communication, and underestimation of the problem on the part of healthcare professionals also play a role. Improving outcomes requires accurate assessment of risk factors, use of guidelines, and better adherence to antiemetic regimens. Conclusion: Extended-release formulations and new delivery systems such as transdermal patches, nasal sprays, and pumps provide a new strategy that may improve patient outcomes.
AB - Introduction: Chemotherapy-induced nausea and vomiting remains a significant problem for cancer patients. Discussion: Patient factors such as polypharmacy, medication costs, mucositis, and depression may hinder good antiemetic control, while high workloads, poor communication, and underestimation of the problem on the part of healthcare professionals also play a role. Improving outcomes requires accurate assessment of risk factors, use of guidelines, and better adherence to antiemetic regimens. Conclusion: Extended-release formulations and new delivery systems such as transdermal patches, nasal sprays, and pumps provide a new strategy that may improve patient outcomes.
KW - Chemotherapy-induced nausea and vomiting
KW - Cisplatin-based therapy
KW - Neurokinin-1 inhibitor
KW - Selective 5-hydroxytrytamine 3
UR - http://www.scopus.com/inward/record.url?scp=84755160773&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84755160773&partnerID=8YFLogxK
U2 - 10.1007/s00520-009-0807-z
DO - 10.1007/s00520-009-0807-z
M3 - Article
C2 - 20084406
AN - SCOPUS:84755160773
VL - 18
SP - S1-S10
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
SN - 0941-4355
IS - SUPPL. 1
ER -